Prelude Capital Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-57,497
| Closed | -$1.34M | – | 1441 |
|
2024
Q3 | $1.34M | Sell |
57,497
-10,139
| -15% | -$237K | 0.08% | 268 |
|
2024
Q2 | $1.2M | Buy |
67,636
+12,036
| +22% | +$214K | 0.08% | 248 |
|
2024
Q1 | $846K | Buy |
55,600
+6,800
| +14% | +$103K | 0.04% | 393 |
|
2023
Q4 | $834K | Sell |
48,800
-9,952
| -17% | -$170K | 0.06% | 282 |
|
2023
Q3 | $491K | Buy |
58,752
+49,430
| +530% | +$413K | 0.03% | 388 |
|
2023
Q2 | $232K | Buy |
+9,322
| New | +$232K | 0.02% | 673 |
|
2023
Q1 | – | Sell |
-37,127
| Closed | -$439K | – | 1345 |
|
2022
Q4 | $439K | Sell |
37,127
-900
| -2% | -$10.6K | 0.02% | 547 |
|
2022
Q3 | $225K | Sell |
38,027
-1,947
| -5% | -$11.5K | 0.01% | 998 |
|
2022
Q2 | $170K | Sell |
39,974
-1,677
| -4% | -$7.13K | ﹤0.01% | 1124 |
|
2022
Q1 | $396K | Buy |
41,651
+1,823
| +5% | +$17.3K | 0.01% | 767 |
|
2021
Q4 | $757K | Buy |
39,828
+846
| +2% | +$16.1K | 0.02% | 577 |
|
2021
Q3 | $1.3M | Buy |
+38,982
| New | +$1.3M | 0.03% | 320 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 1828 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 1690 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 1531 |
|
2019
Q4 | – | Sell |
-100
| Closed | -$1K | – | 1754 |
|
2019
Q3 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 1132 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 1708 |
|
2019
Q1 | – | Sell |
-73
| Closed | – | – | 1726 |
|
2018
Q4 | $0 | Buy |
+73
| New | – | ﹤0.01% | 1730 |
|
2018
Q3 | – | Sell |
-78
| Closed | -$1K | – | 1668 |
|
2018
Q2 | $1K | Buy |
+78
| New | +$1K | ﹤0.01% | 1316 |
|
2014
Q4 | – | Sell |
-2,007
| Closed | -$21K | – | 2023 |
|
2014
Q3 | $21K | Buy |
2,007
+1,582
| +372% | +$16.6K | ﹤0.01% | 1617 |
|
2014
Q2 | $4K | Sell |
425
-8,580
| -95% | -$80.8K | ﹤0.01% | 1674 |
|
2014
Q1 | $62K | Buy |
+9,005
| New | +$62K | 0.01% | 1067 |
|